Primmune Therapeutics jobs and careers
San Diego, CA, United States
About Primmune Therapeutics
Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Their goal is to improve the response rate of patients to current and future immunotherapy medicines.
Founded in 2017 by James Appleman and Paulo Rangel.
- Founded
- 2017
- Employees
- 1 to 10
- Total funding
- $48.3M
- Headquarters
- San Diego
Leadership
The top of Primmune Therapeutics's org chart, with how many people report into each leader.
Charles McDermott
Chairman, President & CEO
7 reports
James Appleman
SVP, R&D & CSO Co-Founder, Director
1 report
Paulo Rangel
Chief Business Officer and Co-founder
1 report
Curtis Scribner
Chief Medical Officer
Marc Veale
Chief Financial Officer
Richard Daniels
Chief Operating Officer
Board
Amir Nashat
Director
Todd Harris
Director
Elina Zuniga
Scientific Advisor
Sheldon Morris
Clinical Advisor
Jyoti Mayadev
Clinical Advisor
Isan Chen
Clinical Advisor
Jobs at Primmune Therapeutics
No open positions right now. Explore more companies on TheJobsMap.